Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
US Army
Harvard Business School
Federal Trade Commission
Boehringer Ingelheim
Johnson and Johnson

Generated: September 21, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Technetium-99m labeled polypeptides for imaging
Abstract:The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention provides peptides which bind technetium-99m and which can be targeted to specific sites within a mammalian body.
Inventor(s): Dean; Richard T. (Bedford, NH)
Assignee: Diatide, Inc. (Londonderry, NH)
Filing Date:Jun 07, 1995
Application Number:08/480,551
Claims:1. A polypeptide reagent for preparing a scintigraphic imaging agent, the reagent comprising, in combination:

(a) a specific binding peptide that specifically binds to a target site to be imaged; and

(b) a technetium binding moiety of the formula

wherein Cp is a protected cysteine amino acid residue and (aa) is any amino acid, the technetium binding moiety being covalently bound to the specific binding peptide, and wherein the reagent has an amino acid sequence of 6 to 100 amino acids.

2. A polypeptide reagent according to claim 1 wherein the specific binding peptide and the technetium binding moiety are covalently linked through from one to about ninety amino acids.

3. A polypeptide reagent according to claim 1 wherein the sidechain sulfur atom of the cysteine residue is protected by a protecting group of the formula

wherein R is lower alkyl having 1 to 6 carbon atoms, phenyl, or phenyl substituted with lower alkyl, hydroxy, lower alkoxy, carboxy, or lower alkoxycarbonyl, or 2-pyridyl, 3-pyridyl, or 4-pyridyl.

4. A polypeptide reagent according to claim 1 wherein the Cp(aa) Cp moiety has the formula:

5. A polypeptide reagent according to claim 1 wherein the specific binding peptide specifically binds to clots, tumors, sites of infection, atherosclerotic plaques, amyloid plaques or bone.

6. A polypeptide reagent according to claim 1 wherein the specific binding peptide is selected from the group consisting of:
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus